Brief: 3Sbio Says Unit And Numab Collaborate To Develop Portfolio Of Novel Multi-Specific Antibodies
Dec 12 (Reuters) - 3SBio Inc 1530.HK :
* SUNSHINE GUOJIAN AND NUMAB COLLABORATE TO DEVELOP A
PORTFOLIO OF
NOVEL MULTI-SPECIFIC ANTIBODIES
Source text for Eikon: ID:nHKS61ZPh4
Further company coverage: 1530.HK
((Reuters.Briefs@thomsonreuters.com;))